@Psyched_Alpha Psychedelic Alpha
Psychedelic Alpha posts on X about atai life, health, $help, $ghrs the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.
Engagements: [-----] #
- [--] Week [-----] -56%
- [--] Month [------] +109%
- [--] Months [-------] +6%
- [--] Year [-------] +51%
Mentions: [--] #
- [--] Week [--] +17%
- [--] Month [--] +80%
- [--] Months [---] +105%
- [--] Year [---] +292%
Followers: [------] #
- [--] Week [------] +0.07%
- [--] Month [------] +0.35%
- [--] Months [------] +2.50%
- [--] Year [------] +5.20%
CreatorRank: [-------] #
Social Influence
Social category influence stocks 26% finance 6% countries 5% exchanges 2% celebrities 2% currencies 1%
Social topic influence atai life 8%, health 6%, $help 5%, $ghrs #4, breaking 5%, $atai 4%, in the 4%, business 3%, $cybn 3%, ind 3%
Top accounts mentioned or mentioned by @shaylalove @profdavidnutt @usfda @joshhardman @sarahlsinclairs @kukeon2022 @pharmatherinc @fabiochianelli @psychedvantage @4andahalffarm @stoopkid2022 @mindlumen @jsoooky
Top assets mentioned Atai Life Sciences B.V. (ATAI) GH Research PLC (GHRS) COMPASS Pathways plc (CMPS) AbbVie Inc (ABBV)
Top Social Posts
Top posts by engagements in the last [--] hours
"Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment https://www.statnews.com/2026/02/04/psilocybin-depression-psychedelic-drug-fast-track-blocked/ https://www.statnews.com/2026/02/04/psilocybin-depression-psychedelic-drug-fast-track-blocked/"
X Link 2026-02-04T13:25Z 21K followers, 11.6K engagements
"Helus Pharma $HELP Appoints New CEO Michael Cola former President of Shire's Specialty Pharma business also a member of Delix Therapeutics' advisory board"
X Link 2026-02-10T13:09Z 21K followers, [---] engagements
"BREAKING: Beckley's 5-MeO-DMT Shows Rapid Durable Antidepressant Effects in Phase 2b Study Read our analysis of the largest study of 5-MeO-DMT: https://psychedelicalpha.com/news/beckleys-5-meo-dmt-shows-rapid-durable-antidepressant-effects-in-phase-2b-study https://psychedelicalpha.com/news/beckleys-5-meo-dmt-shows-rapid-durable-antidepressant-effects-in-phase-2b-study"
X Link 2025-07-01T10:03Z 20.9K followers, [----] engagements
"Compass Pathways Chief Patient Officer Steve Levine MD speaking with Psychedelic Alpha. Read more: https://psychedelicalpha.com/news/bringing-psilocybin-to-market-compass-steve-levine-on-infrastructure-access-and-competition https://psychedelicalpha.com/news/bringing-psilocybin-to-market-compass-steve-levine-on-infrastructure-access-and-competition"
X Link 2025-11-28T16:41Z 20.9K followers, [----] engagements
"Cybin Rebrands to Helus Lists on Nasdaq Psychedelic drug developer Cybin now goes by Helus Pharma and has moved from the NYSE American to the Nasdaq Global Market effective January 5th. The ticker too has changed: from $CYBN to $HELP. Read more: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-217-gilgameshs-gm-1020-prints-positive-topline-fda-lifts-hold-on-gh-researchs-5-meo-dmt-ind-compass-details-pivotal-ptsd-trial-design-cybin-becomes-helus"
X Link 2026-01-08T13:48Z 20.9K followers, [---] engagements
"Sales of Johnson & Johnson's esketamine nasal spray Spravato jumped to $503M in Q4 [----] up around 10% on Q3 equating to a $2bn+ annual run rate"
X Link 2026-01-21T16:40Z 20.9K followers, [----] engagements
"Psychedelic financing activity in [----] was led by public companies Large rounds came from $CMPS $GHRS $ATAI $HELP and $DFTX. More: https://psychedelicalpha.com/news/psychedelic-funding-public-markets-and-ma-in-2025 https://psychedelicalpha.com/news/psychedelic-funding-public-markets-and-ma-in-2025"
X Link 2026-01-22T16:02Z 21K followers, [----] engagements
"Psychedelics Surface in Newly Released Epstein Documents More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-219-trump-admin-vetoed-compass-priority-voucher-ibogaine-in-focus-definium-sued-by-former-vendor-psychedelics-feature-in-epstein-files https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-219-trump-admin-vetoed-compass-priority-voucher-ibogaine-in-focus-definium-sued-by-former-vendor-psychedelics-feature-in-epstein-files"
X Link 2026-02-06T17:49Z 21K followers, [----] engagements
"Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola This morning $HELP announced the appointment of Michael Cola as CEO. Here we share a brief Q&A. https://psychedelicalpha.com/news/taking-the-helm-at-helus-a-brief-qa-with-new-ceo-michael-cola https://psychedelicalpha.com/news/taking-the-helm-at-helus-a-brief-qa-with-new-ceo-michael-cola"
X Link 2026-02-10T14:06Z 20.9K followers, [---] engagements
"Signant Health Sues Definium Therapeutics (formerly MindMed) for Allegedly Stealing Trade Secrets"
X Link 2026-02-03T16:34Z 21K followers, [----] engagements
"Sara Tai Professor of Clinical Psychology and psychedelic therapy researcher spoke to The Psychedelic Practitioner about dosing day. More: https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-12T14:45Z 21K followers, [---] engagements
""Touch carries a weight that other interventions do not and you cannot see what your touch may interact with particularly within the vivid symbolic sensory landscape of psychedelic experience." Read more: https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-14T14:54Z 20.9K followers, [---] engagements
"The U.S. Department of Veterans Affairs (VA) is launching a Phase [--] trial that will see [---] veterans with treatment-resistant depression (TRD) receive one of two doses of Compass Pathways COMP360 psilocybin (either a comparator or intervention dose)"
X Link 2025-11-19T21:42Z 21K followers, [----] engagements
"Psychedelic stocks had a very strong [----] with companies like AtaiBeckley $ATAI Compass Pathways $CMPS GH Research $GHRS and Definium Therapeutics $DFTX outperforming indexes like XBI and S&P500. More: https://psychedelicalpha.com/news/psychedelic-funding-public-markets-and-ma-in-2025 https://psychedelicalpha.com/news/psychedelic-funding-public-markets-and-ma-in-2025"
X Link 2026-01-26T19:28Z 21K followers, [----] engagements
"Emily Fishel a psychotherapist with a specialism in psychedelic-assisted therapy spoke to us about how she manages situations where trial participants appear to receive a placebo or low-dose. Read more: https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-12T20:47Z 21K followers, [---] engagements
"BREAKING: FDA lifts clinical hold on GH Research's inhaled 5-MeO-DMT for treatment-resistant depression IND. $GHRS expects to commence a Phase [--] program this year. https://investor.ghres.com/news-releases/news-release-details/gh-research-announces-fda-lifts-clinical-hold-gh001-clearing https://investor.ghres.com/news-releases/news-release-details/gh-research-announces-fda-lifts-clinical-hold-gh001-clearing"
X Link 2026-01-05T12:01Z 21K followers, [----] engagements
"In an interview Joost Breeksema shared his views on the delivery of psychedelic therapy. Read more: https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy"
X Link 2026-02-05T11:26Z 21K followers, [---] engagements
"DemeRx Posts Positive Phase [--] Noribogaine Readout More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-219-trump-admin-vetoed-compass-priority-voucher-ibogaine-in-focus-definium-sued-by-former-vendor-psychedelics-feature-in-epstein-files https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-219-trump-admin-vetoed-compass-priority-voucher-ibogaine-in-focus-definium-sued-by-former-vendor-psychedelics-feature-in-epstein-files"
X Link 2026-02-06T13:48Z 21K followers, [----] engagements
"UK Advisory Body Rejects Ketamine Reclassification More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-219-trump-admin-vetoed-compass-priority-voucher-ibogaine-in-focus-definium-sued-by-former-vendor-psychedelics-feature-in-epstein-files https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-219-trump-admin-vetoed-compass-priority-voucher-ibogaine-in-focus-definium-sued-by-former-vendor-psychedelics-feature-in-epstein-files"
X Link 2026-02-09T17:50Z 21K followers, [---] engagements
"Out Now: The Psychedelic Practitioner Issue 3: Dosing Read our 10000-word Issue for free. https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-10T13:47Z 21K followers, [---] engagements
"In our latest Issue of The Psychedelic Practitioner Rebecca Lerendu Mbonga spoke to us about how she views challenging experiences. Read more: https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-13T16:49Z 21K followers, [---] engagements
"Tomorrow Compass Pathways will share 6-week data from its second larger Phase [--] study of its psilocybin candidate in treatment-resistant depression. It will also share 26-week data from its first Phase [--]. Psychedelic Alpha has the full story tomorrow AM"
X Link 2026-02-16T15:06Z 21K followers, [----] engagements
"Theres nothing to do reach or achieve In our latest Issue of The Psychedelic Practitioner Helena Aicher gave some advice for therapists working in the field. Read more: https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-16T16:50Z 21K followers, [---] engagements
"Therapy also psychedelic therapy is not only serious. In our latest Issue of The Psychedelic Practitioner Helena Aicher reflected on what she has learned through years of experience in psychedelic therapy. Read more: https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing"
X Link 2026-02-16T17:00Z 21K followers, [---] engagements
""A research team from UNC-Chapel Hill UC San Francisco Yale Duke and Stanford developed a new compound that hits the same brain cell target as psychedelic drugs triggering long-lasting anti-depressant action without psychedelic effects in mice." https://news.unchealthcare.org/2022/09/scientists-create-non-psychedelic-compound-with-same-anti-depressant-effect/ https://news.unchealthcare.org/2022/09/scientists-create-non-psychedelic-compound-with-same-anti-depressant-effect/"
X Link 2022-09-28T20:47Z 20.9K followers, [--] engagements
"BREAKING: Alberta Will Regulate Psychedelics for Use in Therapy Canada's 4th largest province which has a population of [---] million will become the first to regulate psychedelics when rules come into effect in January 2023"
X Link 2022-10-06T00:55Z 20.9K followers, [---] engagements
"BREAKING: COMPASS Pathways' Phase 2b Trial of Psilocybin for Treatment-Resistant Therapy Published in NEJM Becomes the largest published psilocybin trial to date. Quick coverage & analysis to follow"
X Link 2022-11-02T21:01Z 20.9K followers, [---] engagements
"Colorado Looks Set to Decriminalize Psychedelics Provide Legal Psilocybin Therapy Proposition [---] apears to have narrowly passed with 51.03% of counted votes in support of the measure. However the count is not yet final. https://psychedelicalpha.com/psychedelic-news/psychedelics-on-the-ballot-u-s-midterms-2022 https://psychedelicalpha.com/psychedelic-news/psychedelics-on-the-ballot-u-s-midterms-2022"
X Link 2022-11-09T13:48Z 20.9K followers, [--] engagements
"MAPS Completes Second Phase [--] Study of MDMA-Assisted Psychotherapy for PTSD According to the clinical trial registry entry [---] participants were recruited and the study was completed on November 2nd. Slightly ahead of the estimated completion date"
X Link 2022-11-09T19:50Z 20.9K followers, [--] engagements
"1st Berkeley program trains certifies psychedelic guides "This fall [--] people in a first-of-its-kind training program at the year-old UC Berkeley Center for the Science of Psychedelics are learning to safely guide patients psychedelic experiences" https://news.berkeley.edu/2022/11/10/first-ever-uc-berkeley-program-trains-certifies-psychedelic-guides/ https://news.berkeley.edu/2022/11/10/first-ever-uc-berkeley-program-trains-certifies-psychedelic-guides/"
X Link 2022-11-11T10:31Z 20.9K followers, [--] engagements
"'I took magic mushrooms at [--] and the fog I've lived under my whole life lifted' "After successful clinical trials of psilocybin for treating depression there are now calls for its wider use" https://www.telegraph.co.uk/health-fitness/mind/took-magic-mushrooms-64-fog-lived-whole-life-lifted/ https://www.telegraph.co.uk/health-fitness/mind/took-magic-mushrooms-64-fog-lived-whole-life-lifted/"
X Link 2022-11-12T18:57Z 20.9K followers, [---] engagements
"Finland grants license for psychedelic drug therapy study "A Canadian drug firm Clairvoyant is recruiting [--] people in Finland who suffer from alcohol addiction." https://yle.fi/a/3-12676727 https://yle.fi/a/3-12676727"
X Link 2022-11-14T16:01Z 20.9K followers, [--] engagements
"MDMA 'will be rolled out in US hospitals by 2024' MAPS PBC expects to submit a New Drug Application (NDA) to FDA "within months". https://www.dailymail.co.uk/health/article-11481673/MDMA-approved-MONTHS-Rave-drug-statistically-significant-treating-PTSD.html https://www.dailymail.co.uk/health/article-11481673/MDMA-approved-MONTHS-Rave-drug-statistically-significant-treating-PTSD.html"
X Link 2022-12-01T13:25Z 20.9K followers, [---] engagements
"Confirmatory Phase [--] Trial of MDMA Therapy for PTSD is Successful Says MAPS Today MAPS has announced that its second Phase [--] trial of MDMA-assisted therapy (MDMA-AT) for PTSD confirms prior positive results. https://psychedelicalpha.com/news/confirmatory-phase-3-trial-of-mdma-therapy-for-ptsd-is-successful-says-maps https://psychedelicalpha.com/news/confirmatory-phase-3-trial-of-mdma-therapy-for-ptsd-is-successful-says-maps"
X Link 2023-01-05T15:25Z 20.9K followers, [----] engagements
"WHO Gives 5-MeO-DMT Generic Name: Mebufotenin According to its International Nonproprietary Names for Pharmaceutical Substances (INN) list the World Health Organisation has given 5-MeO-DMT the nonproprietary name "mebufoteninum". (Image from Proposed INN list)"
X Link 2023-01-09T18:00Z 20.9K followers, 21.8K engagements
"Today we begin publishing our [----] Year in Review. The series kicks off with an Op-Ed from journalist @shayla__love who is among the most astute observers of the nascent psychedelics industry. https://psychedelicalpha.com/news/after-the-ecstasy-the-laundry-shayla-loves-take-on-psychedelics-in-2022 https://psychedelicalpha.com/news/after-the-ecstasy-the-laundry-shayla-loves-take-on-psychedelics-in-2022"
X Link 2023-01-19T14:33Z 20.9K followers, 22.1K engagements
"BREAKING: Australia Approved Psilocybin and MDMA for Use in Treating Depression and PTSD It will be possible for MDMA to be prescribed for PTSD and Psilocybin for treatment-resistant depression. https://www.abc.net.au/news/2023-02-03/tga-approves-psilocybin-mdma-for-treating-depression-ptsd/101929578 https://www.abc.net.au/news/2023-02-03/tga-approves-psilocybin-mdma-for-treating-depression-ptsd/101929578"
X Link 2023-02-03T10:32Z 20.9K followers, [----] engagements
"Australia Recognises MDMA and Psilocybin as Medicines Makes the country in the world to officially recognise the two drugs as medicines. Our analysis: https://psychedelicalpha.com/news/australia-recognises-mdma-and-psilocybin-as-medicines https://psychedelicalpha.com/news/australia-recognises-mdma-and-psilocybin-as-medicines"
X Link 2023-02-03T12:08Z 20.9K followers, [----] engagements
"Prince Harry Explains Why Psychedelics Are A 'Fundamental' Part Of His Life The Duke of Sussex said the drugs are like the "cleaning of a windshield" for him and help "remove lifes filters." https://www.huffingtonpost.co.uk/entry/prince-harry-psychedelics-fundamental_n_63f92f79e4b0735bf877c912 https://www.huffingtonpost.co.uk/entry/prince-harry-psychedelics-fundamental_n_63f92f79e4b0735bf877c912"
X Link 2023-03-04T23:06Z 20.9K followers, [----] engagements
"Diplo says he ran a marathon while on LSD. Experts say he's tripping. "There isn't notable research to back up any physical boosts Diplo might have gained from taking LSD" https://eu.usatoday.com/story/life/health-wellness/2023/03/25/diplo-ran-la-marathon-lsd-health-experts/11528611002/ https://eu.usatoday.com/story/life/health-wellness/2023/03/25/diplo-ran-la-marathon-lsd-health-experts/11528611002/"
X Link 2023-03-26T09:15Z 20.9K followers, 11K engagements
""I want everyone to appreciate the joy and wonder of every single moment of their lives. We should be astonished that we are here when we look around at the exquisite wonder and beauty of everything." https://www.nytimes.com/interactive/2023/04/03/magazine/roland-griffiths-interview.html https://www.nytimes.com/interactive/2023/04/03/magazine/roland-griffiths-interview.html"
X Link 2023-04-03T10:46Z 20.9K followers, [----] engagements
"American Medical Association to Issue First New Code for Psychedelic Therapies A joint press release from COMPASS Pathways and MAPS PBC details the new code. Full details expected July [----]. https://psychedelicalpha.com/news/american-medical-association-to-issue-first-new-code-for-psychedelic-therapies https://psychedelicalpha.com/news/american-medical-association-to-issue-first-new-code-for-psychedelic-therapies"
X Link 2023-05-02T11:19Z 20.9K followers, [----] engagements
"BREAKING: State of Kentucky Sets Aside $42 Million for Psychedelic Research The money carved out from Opioid Settlement Funds will be used for psychedelic research specifically ibogaine for opioid addiction. The funds will be allocated over seven years"
X Link 2023-05-31T15:28Z 20.9K followers, 63.3K engagements
"The Scottish government has called for the decriminalisation of all drugs for personal use. https://www.bbc.co.uk/news/uk-scotland-66133549.amp https://www.bbc.co.uk/news/uk-scotland-66133549.amp"
X Link 2023-07-07T13:56Z 20.9K followers, [----] engagements
"I'm Giving $100 Million to Psychedelics Research Blake Mycoskie founder of TOMs shoes explains why he's committing a significant sum to support psychedelic research. https://www.newsweek.com/donating-psychedelics-research-philanthropy-1811505 https://www.newsweek.com/donating-psychedelics-research-philanthropy-1811505 https://www.newsweek.com/donating-psychedelics-research-philanthropy-1811505 https://www.newsweek.com/donating-psychedelics-research-philanthropy-1811505"
X Link 2023-07-12T15:24Z 20.9K followers, 20.9K engagements
"I am dying of cancer. Black-market psilocybin gave me a new lease on life. "Mushrooms worked magic on my mental health after a terminal diagnosis. More Canadians should have access to them." https://macleans.ca/society/health/black-market-psilocybin-cancer-treatment/ https://macleans.ca/society/health/black-market-psilocybin-cancer-treatment/"
X Link 2023-07-31T16:38Z 20.9K followers, [----] engagements
"I Went to Rehab for Alcoholism [--] Times. Only Psychedelics Helped Using psilocybin four to six times has managed to achieve what the other therapies didnt do in years. https://www.vice.com/en/article/g5vzg4/psychedelics-helped-alcoholism https://www.vice.com/en/article/g5vzg4/psychedelics-helped-alcoholism"
X Link 2023-08-16T08:55Z 20.9K followers, [----] engagements
"Psilocybin: A cure for alcohol addiction and depression An interview with @ProfDavidNutt. https://www.heraldscotland.com/news/23766196.psilocybin-cure-alcohol-addiction-depression/ https://www.heraldscotland.com/news/23766196.psilocybin-cure-alcohol-addiction-depression/ https://www.heraldscotland.com/news/23766196.psilocybin-cure-alcohol-addiction-depression/ https://www.heraldscotland.com/news/23766196.psilocybin-cure-alcohol-addiction-depression/ https://www.heraldscotland.com/news/23766196.psilocybin-cure-alcohol-addiction-depression/"
X Link 2023-09-09T10:20Z 20.9K followers, 11.7K engagements
"MAPS' Second Phase [--] Study of MDMA-assisted Therapy Reports Positive Results Paving Way for New Drug Application https://psychedelicalpha.com/news/second-phase-3-study-of-mdma-assisted-therapy-reports-positive-results-paving-way-for-new-drug-application https://psychedelicalpha.com/news/second-phase-3-study-of-mdma-assisted-therapy-reports-positive-results-paving-way-for-new-drug-application https://psychedelicalpha.com/news/second-phase-3-study-of-mdma-assisted-therapy-reports-positive-results-paving-way-for-new-drug-application"
X Link 2023-09-14T15:37Z 20.9K followers, [----] engagements
"MDMA as psychiatric treatment moves closer to US approval "Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people." https://www.nature.com/articles/d41586-023-02886-x https://www.nature.com/articles/d41586-023-02886-x"
X Link 2023-09-14T16:05Z 20.9K followers, [----] engagements
"MDMA therapy for PTSD expected to get US approval after latest trial "US regulators could soon authorise MDMA-assisted psychotherapy for post-traumatic stress disorder after positive results in the largest clinical trial to date" https://www.newscientist.com/article/2392213-mdma-therapy-for-ptsd-expected-to-get-us-approval-after-latest-trial/ https://www.newscientist.com/article/2392213-mdma-therapy-for-ptsd-expected-to-get-us-approval-after-latest-trial/"
X Link 2023-09-14T16:15Z 20.9K followers, 18.5K engagements
"On Monday evening Roland Griffiths a pioneer in psychedelic and consciousness research passed away. Beyond Griffiths' immense impact on the field of psychedelic research his legacy includes a Professorship Fund in Psychedelic Research on Secular Spirituality and Well Being"
X Link 2023-10-17T13:28Z 20.9K followers, [----] engagements
"Our 150th Bulletin just published. This Issue primarily focuses on psychedelic drug development and business stories with around [----] words of coverage and analysis. Stories include: - GH Researchs Lead 5-MeO-DMT Candidate Faces Development Hiccup Potential Hold-Up - Psychae Therapeutics Scores AUD $4.5m to Develop DMT-Based Candidate Cybin Closes $30m Offering - Brain & Behavior Research Foundation Awards Grants to [--] Young Investigators Exploring Psychedelics - atai Buys Out Remainder of DemeRxs Ibogaine Asset; Announces Novel 5-HT2A Agonist Candidates - Compass Pathways Commences UK Portion"
X Link 2023-11-28T23:34Z 20.9K followers, [---] engagements
"BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD Filing marks the first NDA submission for any psychedelic-assisted therapy https://psychedelicalpha.com/news/breaking-maps-pbc-files-new-drug-application-for-mdma-assisted-therapy-for-ptsd https://psychedelicalpha.com/news/breaking-maps-pbc-files-new-drug-application-for-mdma-assisted-therapy-for-ptsd"
X Link 2023-12-12T14:26Z 20.9K followers, 13.2K engagements
""The Department of Veterans Affairs will fund research on the use of psychedelic drugs like MDMA and psilocybin along with therapy to treat post-traumatic stress disorder and depression the agency announced Friday." https://subscriber.politicopro.com/article/2024/01/va-to-fund-psychedelic-research-00134043 https://subscriber.politicopro.com/article/2024/01/va-to-fund-psychedelic-research-00134043"
X Link 2024-01-05T19:34Z 20.9K followers, 17.4K engagements
"The FDA has accepted Lykos Therapeutics (formerly MAPS PBC) New Drug Application for MDMA-assisted therapy for PTSD. The agency also granted Priority Review and set a target PDUFA date of August [--] [----] meaning Lykos should expect a decision by that time"
X Link 2024-02-10T12:32Z 20.9K followers, 46.4K engagements
"MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder https://finance.yahoo.com/news/mindmed-receives-fda-breakthrough-therapy-110000670.html https://finance.yahoo.com/news/mindmed-receives-fda-breakthrough-therapy-110000670.html"
X Link 2024-03-07T11:24Z 20.9K followers, [----] engagements
"MindMed becomes the fourth organisation to receive such FDA Breakthrough Therapy Designation for a psychedelic drug candidate. Previously MAPS Compass Pathways and Usona Institute received the designation for MDMA and psilocybin (x2) respectively. MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder https://t.co/P9JTMTO94s MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder"
X Link 2024-03-07T11:33Z 20.9K followers, [----] engagements
"P+ Psychedelic Patent Analysis: April [----] - A CaaMTech & ASRI Collaboration - GH Research & Beckley Psytech: An Update - CaaMTech Grows Tryptamine Patent Portfolio - Atai Sees Two New Allowances to Support DMT Program https://twitter.com/i/web/status/1794080662925832491 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-april-2024 https://twitter.com/i/web/status/1794080662925832491 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-april-2024"
X Link 2024-05-24T18:58Z 20.9K followers, [---] engagements
"BREAKING: FDA Rejects Lykos Therapeutics MDMA-Assisted Therapy For PTSD FDA requests additional Phase [--] study from Lykos. The company says it will request a meeting with the agency and urge it to reconsider its decision. https://psychedelicalpha.com/news/breaking-fda-rejects-lykos-therapeutics-mdma-assisted-therapy-for-ptsd https://psychedelicalpha.com/news/breaking-fda-rejects-lykos-therapeutics-mdma-assisted-therapy-for-ptsd"
X Link 2024-08-09T21:39Z 20.9K followers, 67.3K engagements
"Richard Branson calls for 'ending the failed war on drugs' ".I think as more data becomes available and as more products are developed psychedelics-assisted treatment will become commonplace." https://www.virgin.com/branson-family/richard-branson-blog/reducing-harm-with-psychedelics https://www.virgin.com/branson-family/richard-branson-blog/reducing-harm-with-psychedelics"
X Link 2024-09-16T18:15Z 20.9K followers, [----] engagements
"The VA is undeterred on psychedelics The Department of Veterans Affairs remains convinced that psychedelic therapy can help treat veterans with post-traumatic stress disorder and its going to try to prove it. https://www.politico.com/newsletters/future-pulse/2024/10/30/the-va-is-undeterred-on-psychedelics-00186199 https://www.politico.com/newsletters/future-pulse/2024/10/30/the-va-is-undeterred-on-psychedelics-00186199"
X Link 2024-10-30T21:02Z 20.9K followers, [----] engagements
"P+ Psychedelic Bulletin #186 - As Trump Takes Office Impact on Psychedelics Field Remains Unclear - The Jurvetsons Discuss Psychedelics at DLD - GH Research Shares PoC Data - more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-186-as-trump-takes-office-impact-on-psychedelics-field-remains-unclear-the-jurvetsons-discuss-psychedelics-at-dld-gh-shares-poc-data https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-186-as-trump-takes-office-impact-on-psychedelics-field-remains-unclear-the-jurvetsons-discuss-psychedelics-at-dld-gh-shares-poc-data"
X Link 2025-01-24T16:40Z 20.9K followers, [----] engagements
"GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression We take a closer look at the studys design todays topline efficacy and safety readout the commercial case for GH001 and the path ahead for the company https://psychedelicalpha.com/news/gh-research-reports-strong-phase-2b-results-for-5-meo-dmt-in-treatment-resistant-depression https://psychedelicalpha.com/news/gh-research-reports-strong-phase-2b-results-for-5-meo-dmt-in-treatment-resistant-depression"
X Link 2025-02-03T16:07Z 21K followers, [----] engagements
"HHS Sec. Kennedy suggests he wants to see psychedelic-based therapies available at least to veterans within [--] months. Psychedelic therapies show real promise for veterans and others battling trauma. Were accelerating clinical trials at @US_FDA with urgencyand working to ensure safe science-based access within [--] months. Some therapies cant wait. https://t.co/GDvccSleEJ Psychedelic therapies show real promise for veterans and others battling trauma. Were accelerating clinical trials at @US_FDA with urgencyand working to ensure safe science-based access within [--] months. Some therapies cant"
X Link 2025-06-24T20:49Z 20.9K followers, [----] engagements
"RFK Jr. Says Access to Psychedelic Therapies to Happen Within [--] Months He was responding to a question from Rep. Dan Crenshaw (R)"
X Link 2025-06-25T15:24Z 20.9K followers, 17.8K engagements
"Lorde Gets Over Stage Fright with MDMA-Assisted Therapy Speaking with Stephen Colbert on The Late Show Kiwi singer Lorde said that MDMA-assisted therapy truly changed the game on my stage fright"
X Link 2025-06-29T19:02Z 20.9K followers, 10.7K engagements
"FDA Maintains Clinical Hold on GH Researchs U.S. 5-MeO-DMT IND GH is in a close race with Beckley Psytech which should soon merge with atai Life Sciences to launch a pivotal program for the same underlying drug and indication"
X Link 2025-07-23T13:36Z 21K followers, [---] engagements
"June [----] Psychedelic Patent Update We added [--] PCTs and [--] U.S. patent applications focused on psychedelics to our tracker in June [----]. New entries came from the likes of Soneria PBC atai Life Sciences 2A Biosciences Delix Therapeutics Compass Pathways Xylo Bio and more. https://psychedelicalpha.com/news/june-2025-psychedelic-patent-update https://psychedelicalpha.com/news/june-2025-psychedelic-patent-update"
X Link 2025-07-24T17:59Z 20.9K followers, [----] engagements
"P+ Psychedelic Bulletin #204 📍 FDA Keeps GH Researchs 5-MeO-DMT on Ice 📍 Makarys Priority Voucher Pilot Launches Mentions Innovative PTSD Treatments 📍 HALT Fentanyl Act Could Streamline Schedule I Research 📍 and more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-204-fda-keeps-gh-researchs-5-meo-dmt-on-ice-makarys-priority-voucher-pilot-launches-mentions-innovative-ptsd-treatments-halt-fentanyl-act-could-streamline-schedule-i-resea"
X Link 2025-07-25T14:14Z 20.9K followers, [---] engagements
"BREAKING: German regulators have green-lit the EU's first psilocybin compassionate access program. Unlike other countries pre-approval pathways Germanys does not require case-by-case regulatory approval and may see insurers cover costs. Details: https://psychedelicalpha.com/news/germany-establishes-eus-first-psilocybin-compassionate-access-program https://psychedelicalpha.com/news/germany-establishes-eus-first-psilocybin-compassionate-access-program"
X Link 2025-07-31T08:03Z 20.9K followers, 10.8K engagements
"atai Life Sciences Phase 2b trial of its non-psychedelic candidate inidascamine (RL-007) in patients with cognitive impairment associated with schizophrenia failed to meet statistical significance on the primary endpoint. The company will not fund further development of the candidate and described the company developing RL-007 Recognify Life Sciences as a strategic investment (according to filings atai owns the majority of the company). Company execs shrugged off the miss emphasising their commitment to their psychedelics compounds. Indeed while atai emphasised its hub-and-spoke model that"
X Link 2025-08-08T13:52Z 20.9K followers, [----] engagements
"Our Editor @Josh__Hardman was quoted in @sarahlsinclair_'s Forbes article last week. There he shared his thoughts on the EU's first psilocybin compassionate use program. Read more: https://www.forbes.com/sites/sarahsinclair/2025/08/07/germany-approves-eus-first-psilocybin-access-program/ https://www.forbes.com/sites/sarahsinclair/2025/08/07/germany-approves-eus-first-psilocybin-access-program/"
X Link 2025-08-11T15:19Z 20.9K followers, [----] engagements
"BREAKING: Norway Approves Public Funding for Generic Ketamine in Treatment-Resistant Depression In a world-first move approves national reimbursement for off-label use of generic ketamine in treatment-resistant depression effective immediately. https://psychedelicalpha.com/news/norway-approves-public-funding-for-generic-ketamine-in-treatment-resistant-depression https://psychedelicalpha.com/news/norway-approves-public-funding-for-generic-ketamine-in-treatment-resistant-depression"
X Link 2025-08-25T09:03Z 20.9K followers, [----] engagements
"AbbVie to Acquire Gilgameshs Bretisilocin for Up to $1.2B We take a closer look at the acquisition what it might tell us about big pharma's interest in the field and what it might mean for the broader crop of psychedelic drug developers. https://psychedelicalpha.com/news/abbvie-to-acquire-gilgameshs-bretisilocin-for-up-to-1-2b https://psychedelicalpha.com/news/abbvie-to-acquire-gilgameshs-bretisilocin-for-up-to-1-2b"
X Link 2025-08-25T14:23Z 20.9K followers, [----] engagements
"The U.S. Drug Enforcement Administration (DEA) has transmitted a petition to move psilocybin to Schedule II to the Department of Health and Human Services (HHS). Read more: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-207-lykos-rebrands-to-resilient-pharma-pushes-back-on-norways-ketamine-reimbursement-decision-abbvie-gilgamesh-deal-viewed-as-validation https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-207-lykos-rebrands-to-resilient-pharma-pushes-back-on-norways-ketamine-reimbursement-decision-abbvie-gilgamesh-deal-viewed-as-validation"
X Link 2025-09-02T16:29Z 20.9K followers, 16.3K engagements
"@Kukeon2022 @Pharmather_Inc @FabioChianelli Hello we do not include manufacturers of generic ketamine"
X Link 2025-09-17T07:05Z 20.9K followers, [---] engagements
"Last week atai Life Sciences announced that it has been awarded a UG3/UGH grant from NIDA to optimise and develop a suite of non-hallucinogenic 5-HT2A/2C receptor agonists for opioid use disorder (OUD). Read more in Bulletin 209: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-209-aussie-insurer-covers-psilocybin-for-trd-atai-scores-11-4m-nida-grant-first-look-at-real-world-outcomes-from-oregon-psilocybin-clients-pipeline-updates"
X Link 2025-09-29T19:48Z 20.9K followers, [---] engagements
"atai Life Sciences and Beckley Psytech have announced the completion of their strategic combination with the combined entity called AtaiBeckley"
X Link 2025-11-08T16:07Z 20.9K followers, [----] engagements
"Speaking to Psychedelic Alpha Compass Pathways Chief Patient Officer Steve Levine MD discussed the psilocybin developer's ex-U.S. launch plans. Read more: https://psychedelicalpha.com/news/bringing-psilocybin-to-market-compass-steve-levine-on-infrastructure-access-and-competition https://psychedelicalpha.com/news/bringing-psilocybin-to-market-compass-steve-levine-on-infrastructure-access-and-competition"
X Link 2025-12-01T16:42Z 20.9K followers, [----] engagements
"Helus Pharma (formerly Cybin) Rings Nasdaq Opening Bell $CYBN becomes $HELP"
X Link 2026-01-06T14:31Z 20.9K followers, [----] engagements
"We're attending Compass Pathways' Event The company is set to discuss its PTSD development program launch planning for a potential approval in treatment-resistant depression and more"
X Link 2026-01-07T15:05Z 20.9K followers, [----] engagements
"$GHRS shares up 22.7% over past month and 43% this week following lifting of FDA clinical hold. $ATAI its main competitor down 10% over past month trading flat over past week"
X Link 2026-01-08T12:29Z 20.9K followers, [----] engagements
"FDA Lifts Hold on GH Researchs Inhaled 5-MeO-DMT IND After More than Two Years Read more: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-217-gilgameshs-gm-1020-prints-positive-topline-fda-lifts-hold-on-gh-researchs-5-meo-dmt-ind-compass-details-pivotal-ptsd-trial-design-cybin-becomes-helus https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-217-gilgameshs-gm-1020-prints-positive-topline-fda-lifts-hold-on-gh-researchs-5-meo-dmt-ind-compass-details-pivotal-ptsd-trial-design-cybin-becomes-helus"
X Link 2026-01-08T19:43Z 20.9K followers, [---] engagements
"Breaking: New Jersey Governor Signs $6M Psilocybin Research Pilot Program Into Law"
X Link 2026-01-20T20:56Z 20.9K followers, [----] engagements
"P+ is the insiders guide to the business policy and science of psychedelics. Independent data-driven reporting analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. https://psychedelicalpha.com/join https://psychedelicalpha.com/join"
X Link 2025-09-11T15:00Z 21K followers, [----] engagements
"In our latest interview we spoke with Joost Breeksema about a wide range of topics including non-pharmacological elements of the PsyPal research program. Read more: https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy"
X Link 2026-01-28T14:23Z 21K followers, [---] engagements
"We added10 PCTs and [--] U.S. patent applicationsfocused on psychedelics to our tracker in August [----]. New entries came from the likes ofLuminous Mind Huxley Health atai Life Sciences TRIPP Gilgamesh Pharmaceuticals CaaMTechand more. https://psychedelicalpha.com/news/august-2025-psychedelic-patent-update https://psychedelicalpha.com/news/august-2025-psychedelic-patent-update"
X Link 2025-09-09T14:47Z 20.9K followers, [---] engagements
"atai Life Sciences and Beckley Psytech have shared topline data from a Phase 2a open-label study of intranasal 5-MeO-DMT (BPL-003) that saw patients with treatment-resistant depression receive an [--] mg dose followed by a [--] mg dose two weeks later. The data represents [--] patients. Read more in Bulletin 209: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-209-aussie-insurer-covers-psilocybin-for-trd-atai-scores-11-4m-nida-grant-first-look-at-real-world-outcomes-from-oregon-psilocybin-clients-pipeline-updates"
X Link 2025-09-24T19:47Z 20.9K followers, [----] engagements
"💵 Funding Follows Sentiment: Psychedelic Sector on Pace for Best Quarter Since Q2 [----] Oct saw $500M invested in psychedelics across just [--] public offerings: 📌 atai $ATAI Life Sciences raised $150M 📌 Cybin $CYBN brought in $175M 📌 MindMed $MNMD announced a $225M raise"
X Link 2025-10-31T20:05Z 20.9K followers, [----] engagements
"P+ Psychedelic Bulletin #217: - Gilgameshs GM-1020 Prints Positive Topline - FDA Lifts Hold on GH Researchs 5-MeO-DMT IND - Compass Details Pivotal PTSD Trial Design - Cybin Becomes Helus - much more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-217-gilgameshs-gm-1020-prints-positive-topline-fda-lifts-hold-on-gh-researchs-5-meo-dmt-ind-compass-details-pivotal-ptsd-trial-design-cybin-becomes-helus"
X Link 2026-01-08T13:21Z 20.9K followers, [----] engagements
"In our latest interview we spoke with Joost J. Breeksema about a wide range of topics including his views on microdosing and neuroplastogens. Read more: https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy"
X Link 2026-01-27T11:21Z 20.9K followers, [---] engagements
"INTEGRATE an EU-funded doctoral network focused on psychedelics has posted [--] funded PhD positions across a variety of disciplines: from basic science through to health economics. More info: https://jobs.psychedelicalpha.com/ https://jobs.psychedelicalpha.com/"
X Link 2026-01-27T16:34Z 20.9K followers, [---] engagements
"As psychedelics become more visible and accessible in diverse contexts conversation is shifting from whether they will go mainstream to how that mainstreaming unfolds and what guardrails are needed to support safety and equity. Op-Ed: https://psychedelicalpha.com/news/op-ed-from-psychedelic-prohibition-to-psychedelic-public-health https://psychedelicalpha.com/news/op-ed-from-psychedelic-prohibition-to-psychedelic-public-health"
X Link 2026-01-28T15:32Z 20.9K followers, [---] engagements
"We spoke with Joost Breeksema about a wide range of topics including his views on microdosing and neuroplastogens. Read more: https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy https://psychedelicalpha.com/news/changes-are-never-linear-joost-breeksema-on-the-human-side-of-psychedelic-therapy"
X Link 2026-02-02T14:25Z 20.9K followers, [---] engagements
"UK's Advisory Council on the Misuse of Drugs Calls for Ketamine to Remain a Class B Substance The UK government had sought Class A placement but its advisory council has recommended otherwise. https://www.gov.uk/government/publications/ketamine-an-updated-review-of-use-and-harms/ketamine-an-updated-review-of-use-and-harms-accessible https://www.gov.uk/government/publications/ketamine-an-updated-review-of-use-and-harms/ketamine-an-updated-review-of-use-and-harms-accessible"
X Link 2026-02-03T10:50Z 20.9K followers, [---] engagements
"GH Research plc Submits IND Hold Response to FDA as 5-MeO-DMT Race Heats Up Irish 5-MeO-DMT drug developer GH Research announced last Friday that it has submitted its response to FDAs clinical hold of its investigational new drug application ahead of schedule. The hold is preventing the company from launching studies of its lead candidate GH001 (inhaled 5-MeO-DMT) in the country. Given that Beckley Psytech is nipping at its heels with an imminent Phase 2b readout and merger with atai Life Sciences GH will be hoping for a swift response from the agency. Read more in Bulletin 202:"
X Link 2025-06-28T13:54Z 21K followers, [---] engagements
"Beckley and atai Leadership Unpack Phase 2b Data Take Aim at GH Research's Dosing Model Our notes from this morning's conference call where company leadership discussed the BPL-003 results and took aim at their closest competitor's model. Read more: https://psychedelicalpha.com/news/beckley-and-atai-leadership-unpack-phase-2b-data-take-aim-at-ghs-dosing-model https://psychedelicalpha.com/news/beckley-and-atai-leadership-unpack-phase-2b-data-take-aim-at-ghs-dosing-model"
X Link 2025-07-01T16:25Z 21K followers, [----] engagements
"FDA Maintains Clinical Hold on GH Research's U.S. Trial $GHRS cannot commence studies in the U.S. as FDA requests further information on respiratory tract histology findings. GH is racing $ATAI/Beckley Psytech to launch the world's first Phase [--] program of 5-MeO-DMT both targeting TRD. https://twitter.com/i/web/status/1948008422219145291 https://twitter.com/i/web/status/1948008422219145291"
X Link 2025-07-23T13:12Z 21K followers, [----] engagements
"⚖ January [----] Psychedelic Bill Round-Up: [--] Bills in Flight. and Counting Legislative sessions across the U.S. have got off to a lively start this year with dozens of new psychedelics-related bills introduced. https://psychedelicalpha.com/news/january-2026-psychedelic-bill-round-up https://psychedelicalpha.com/news/january-2026-psychedelic-bill-round-up"
X Link 2026-01-30T15:37Z 21K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing